Viewing Study NCT02822495


Ignite Creation Date: 2025-12-24 @ 1:15 PM
Ignite Modification Date: 2026-02-26 @ 6:53 AM
Study NCT ID: NCT02822495
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2023-06-15
First Post: 2016-06-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies
Sponsor: Atara Biotherapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module